* Edwards Lifesciences Corp EW.N reported quarterly
adjusted
earnings of 59 cents per share for the quarter ended December
31, lower than the same quarter last year, when the company
reported EPS of 64 cents. The mean expectation of twenty
seven analysts for the quarter was for earnings of 55 cents per
share. Wall Street expected results to range from 53 cents to 64
cents per share.
* Revenue fell 9.7% to $1.39 billion from a year ago;
analysts
expected $1.36 billion.
* Edwards Lifesciences Corp's reported EPS for the quarter
was 58
cents.
* The company reported quarterly net income of $345 million.
* Edwards Lifesciences Corp shares had fallen by 4.0% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 15 "strong buy" or "buy," 18
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Edwards
Lifesciences Corp is $78.07
This summary was machine generated from LSEG data February 11 at
10:38 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 0.55 0.59 Beat
Sep. 30 2024 0.64 0.67 Beat
Jun. 30 2024 0.69 0.70 Beat
Mar. 31 2024 0.64 0.66 Beat